<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9951537</article-id>
    <article-id pub-id-type="publisher-id">5176</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-023-05176-5</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PredAOT: a computational framework for prediction of acute oral toxicity based on multiple random forest models</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Ryu</surname>
          <given-names>Jae Yong</given-names>
        </name>
        <address>
          <email>jyryu@duksung.ac.kr</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jang</surname>
          <given-names>Woo Dae</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jang</surname>
          <given-names>Jidon</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Oh</surname>
          <given-names>Kwang-Seok</given-names>
        </name>
        <address>
          <email>ksoh@krict.re.kr</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.410884.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0532 6173</institution-id><institution>Department of Biotechnology, </institution><institution>Duksung Women’s University, </institution></institution-wrap>33 Samyang-Ro 144-Gil, Dobong-gu, Seoul, 01369 Republic of Korea </aff>
      <aff id="Aff2"><label>2</label>Center for Research and Development, Oncocross Ltd., Seoul, Republic of Korea </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.29869.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2296 8192</institution-id><institution>Data Convergence Drug Research Center, </institution><institution>Korea Research Institute of Chemical Technology, </institution></institution-wrap>141, Gajeong-ro, Yuseong-gu, Daejeon, 34114 Republic of Korea </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.412786.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1791 8264</institution-id><institution>Department of Medicinal and Pharmaceutical Chemistry, </institution><institution>University of Science and Technology, </institution></institution-wrap>176 Gajeong-Ro, Yuseong-gu, Daejeon, 34129 Republic of Korea </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>66</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>6</day>
        <month>2</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Acute oral toxicity of drug candidates can lead to drug development failure; thus, predicting the acute oral toxicity of small compounds is important for successful drug development. However, evaluation of the acute oral toxicity of small compounds considered in the early stages of drug discovery is limited because of cost and time. Here, we developed a computational framework, PredAOT, that predicts the acute oral toxicity of small compounds in mice and rats.</p>
      </sec>
      <sec>
        <title>Methods</title>
        <p id="Par2">PredAOT is based on multiple random forest models for the accurate prediction of acute oral toxicity. A total of 6226 and 6238 compounds evaluated in mice and rats, respectively, were used to train the models.
</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par3">PredAOT has the advantage of predicting acute oral toxicity in mice and rats simultaneously, and its prediction performance is similar to or better than that of existing tools.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p id="Par4">PredAOT will be a useful tool for the quick and accurate prediction of the acute oral toxicity of small compounds in mice and rats during drug development.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Acute oral toxicity</kwd>
      <kwd>Machine learning</kwd>
      <kwd>Random forest</kwd>
      <kwd>Drug discovery</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id>
            <institution>National Research Foundation of Korea</institution>
          </institution-wrap>
        </funding-source>
        <award-id>NRF-2020R1C1C1003218</award-id>
        <principal-award-recipient>
          <name>
            <surname>Ryu</surname>
            <given-names>Jae Yong</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003704</institution-id>
            <institution>Korea Research Institute of Chemical Technology</institution>
          </institution-wrap>
        </funding-source>
        <award-id>SI2231-30-0221082086810001</award-id>
        <award-id>SI2231-30-0221082086810001</award-id>
        <award-id>SI2231-30-0221082086810001</award-id>
        <award-id>SI2231-30-0221082086810001</award-id>
        <principal-award-recipient>
          <name>
            <surname>Ryu</surname>
            <given-names>Jae Yong</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>Woo Dae</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>Jidon</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>Kwang-Seok</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par20">After evaluating the effectiveness of drugs in the process of discovery and development of new drugs, preclinical tests were performed to evaluate their toxicity in animals prior to clinical trials [<xref ref-type="bibr" rid="CR1">1</xref>]. Preclinical toxicity testing can predict toxic responses in humans, determine safe doses in clinical trials, and monitor toxicity-related symptoms and target organs in patients [<xref ref-type="bibr" rid="CR2">2</xref>]. After having confirmed the safety of drugs by evaluating various toxicities, such as acute toxicity, nephrotoxicity, cardiotoxicity, reproductive toxicity, and genotoxicity, clinical trials can be performed.</p>
    <p id="Par21">Acute toxicity is defined as deleterious toxicological effects of a chemical from single or multiple exposures over a short duration (usually &lt; 24 h) [<xref ref-type="bibr" rid="CR3">3</xref>]. Studies on acute toxicity have examined various routes of exposure (e.g., oral, dermal, and inhalation) using rodents, such as mice and rats, to assess lethal doses. During the drug development process, acute toxicity is generally evaluated using acute oral toxicity (AOT) tests that assess acute toxic reactions and the lethal dose 50 (LD<sub>50</sub>) after a single oral administration to rodents [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The LD<sub>50</sub> is defined as the dose of the test substance that can kill 50% of animals within 24 h of exposure.</p>
    <p id="Par22">AOT tests in animals are conducted after confirming the efficacy of a drug [<xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, if drug development fails owing to AOT at this stage, economic loss of development costs incurs. However, as dozens to thousands of compounds are considered drug candidates in the early stages of development, performing AOT tests on all compounds is limited by time and cost issues. Therefore, it is important to evaluate the AOT of such compounds in the early stages of drug development.</p>
    <p id="Par23">To address these issues, various prediction models have been developed based on the results of AOT tests of thousands of compounds [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. In addition, various software programs that predict the AOT of small compounds based on machine learning models are currently available [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. However, several aspects need to be improved for the development of an AOT prediction model. First, it is necessary to develop a computational framework that can predict the AOT in both mice and rats. AOT evaluation of small compounds is still being performed using either mice or rats. Second, it is necessary to further improve the prediction performance of models. One strategy to improve the performance of a model is to build it so that it can properly consider the distribution of the data. For example, using data composed of skewed LD<sub>50</sub> values for model training may reduce prediction performance [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
    <p id="Par24">In the present study, we propose a new computational framework, PredAOT, that predicts the AOT for a given compound in mice and rats. PredAOT is based on multiple random forest models for AOT prediction. For the development of PredAOT, we used a total of 6,226 and 6,238 compounds whose AOT was evaluated in mice and rats, respectively. Moreover, we compared the prediction performance of PredAOT with that of other existing tools. PredAOT is a useful tool for predicting the acute oral toxicity of small compounds during drug development.</p>
  </sec>
  <sec id="Sec2">
    <title>Results and discussion</title>
    <sec id="Sec3">
      <title>Development of the PredAOT framework</title>
      <p id="Par25">To develop a computational framework (i.e., PredAOT) for accurate prediction of AOT, we first collected data on the AOT of compounds (i.e., LD<sub>50</sub>) reported for mice and rats. The AOT data for mice for 6226 compounds were obtained from the OCHEM database [<xref ref-type="bibr" rid="CR7">7</xref>]. The AOT data for rats for 6238 compounds were obtained from the literature [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p id="Par26">According to the GHS Classification, the AOT level of compounds can be divided into five categories [<xref ref-type="bibr" rid="CR12">12</xref>] (Table <xref rid="Tab1" ref-type="table">1</xref>). For example, compounds in Category 1 are toxic, while Category 5 compounds are less likely to be toxic. Additionally, we found that the distribution of LD<sub>50</sub> values for the compounds was skewed towards categories 4 and 5 in both mice and rats. This data imbalance can adversely affect model training, such as overfitting. To address this issue, we decided to classify the AOT of compounds into two categories (i.e., “toxic” and “less or non-toxic”) instead of five categories (Table <xref rid="Tab2" ref-type="table">2</xref>); compounds with LD<sub>50</sub> ≤ 300 mg/kg and compounds with LD<sub>50</sub> &gt; 300 mg/kg. Notably, although a compound is classified as less or non-toxic, it does not necessarily have to involve no AOT at all. During the model development, LD<sub>50</sub> values were transformed to log10 transformed LD<sub>50</sub> values.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Number of compounds in datasets for each acute oral toxicity category</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Toxicity category</th><th align="left">LD<sub>50</sub> (mg/kg)</th><th align="left">Hazard statement</th><th align="left">Mouse</th><th align="left">Rat</th></tr></thead><tbody><tr><td align="left">Category 1</td><td align="left">&lt; 5</td><td align="left">Fatal</td><td align="left">67</td><td align="left">173</td></tr><tr><td align="left">Category 2</td><td align="left">5–50</td><td align="left">Fatal</td><td align="left">282</td><td align="left">490</td></tr><tr><td align="left">Category 3</td><td align="left">50–300</td><td align="left">Toxic</td><td align="left">1183</td><td align="left">1103</td></tr><tr><td align="left">Category 4</td><td align="left">300–2000</td><td align="left">Harmful</td><td align="left">3413</td><td align="left">2560</td></tr><tr><td align="left">Category 5</td><td align="left">2000–5000</td><td align="left">May be harmful</td><td align="left">1281</td><td align="left">1912</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Number of compounds in the “less or non-toxic” and “toxic” datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Less or non-toxic</th><th align="left">Toxic</th></tr></thead><tbody><tr><td align="left">Mouse</td><td char="," align="char">4,694</td><td char="," align="char">1,532</td></tr><tr><td align="left">Rat</td><td char="," align="char">4,472</td><td char="," align="char">1,766</td></tr></tbody></table></table-wrap></p>
      <p id="Par27">We then used the datasets to train a binary classification model, called “AOT classifier,” that predicts AOT as toxic (i.e., LD<sub>50</sub> ≤ 300 mg/kg) or less or non-toxic (i.e., LD<sub>50</sub> &gt; 300 mg/kg) for a given compound. In addition, as shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, toxic and less or non-toxic datasets were used to train two regression models called “toxic regressor” and “less or non-toxic regressor”, respectively. In particular, the “toxic regressor” was trained with the toxic dataset (i.e., LD<sub>50</sub> ≤ 300 mg/kg) and the “less or non-toxic regressor” was trained with the less or non-toxic dataset (i.e., LD<sub>50</sub> &gt; 300 mg/kg).<fig id="Fig1"><label>Fig. 1</label><caption><p>Overall scheme of PredAOT. PredAOT uses the chemical structure as an input. Thereafter, the molecular fingerprint (i.e., ECFP4) is used as an input feature for models in PredAOT. PredAOT is composed of one classification model (i.e., “AOT classifier”) and two regression models (i.e., “toxic regressor” and “less or non-toxic regressor”). The AOT classifier is used for prediction as “toxic” (LD<sub>50</sub> ≤ 300 mg/kg) or “less or non-toxic” (LD<sub>50</sub> &gt; 300 mg/kg) for a given compound. If a compound is predicted to be toxic, PredAOT predicts the LD<sub>50</sub> of the compound using the toxic regressor trained with compounds with LD<sub>50</sub> ≤ 300 mg/kg. If a compound is predicted to be less or non-toxic, PredAOT predicts the LD<sub>50</sub> of the compound using the less or non-toxic regressor trained with compounds with LD<sub>50</sub> &gt; 300 mg/kg. All these procedures are equally applied to the AOT prediction process in mice and rats</p></caption><graphic xlink:href="12859_2023_5176_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par28">To summarize the AOT prediction process in the PredAOT, “AOT classifier” first predicts AOT as “toxic” or “less or non-toxic” for a given compound. Thereafter, if a compound is predicted as toxic, the “toxic regressor” predicts the LD<sub>50</sub> of the compound; otherwise, the “less or non-toxic regressor” predicts the LD<sub>50</sub> of the compound. All procedures were equally applied to the AOT prediction process in mice and rats.</p>
    </sec>
    <sec id="Sec4">
      <title>Optimization and evaluation of AOT prediction models</title>
      <p id="Par29">To build an optimal AOT prediction model, we constructed and evaluated six different machine learning models: a message passing neural network (MPNN) based on graph neural networks, MPNN with molecular fingerprints, MPNN with molecular descriptors, random forest (RF), support vector machine (SVM), and artificial neural network (ANN) models based on molecular fingerprints (see <xref rid="Sec7" ref-type="sec">Materials and Methods</xref>). The training dataset was used for model training to determine the model with the best prediction performance. A test dataset was used to assess the performance of the final model.</p>
      <p id="Par30">First, we optimized the binary classification model (i.e., “AOT classifier”) used to predict the AOT of a given compound in mice and rats. To this end, we evaluated various hyperparameters using a grid search technique with fivefold cross-validation, and used accuracy as the model performance metric. RF showed the highest accuracy for mice (0.8672) and rats (0.8377; Fig. <xref rid="Fig2" ref-type="fig">2</xref>). To further improve the prediction performance of the RF model, we applied an oversampling approach to manage imbalanced data (Table <xref rid="Tab2" ref-type="table">2</xref>). Specifically, we used the synthetic minority oversampling technique (SMOTE), which is a popular algorithm used to generate artificial data [<xref ref-type="bibr" rid="CR13">13</xref>]. In doing so, RF with SMOTE showed better prediction performance than RF without SMOTE: accuracies of 0.9586 and 0.9335 in mice and rats, respectively (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). In addition, we evaluated the prediction performance using the test dataset. The RF model with SMOTE showed an area under the receiver operating characteristic (AUROC) of 0.7778, Matthew’s correlation coefficient (MCC) of 0.5514, positive predictive value (PPV) of 0.6627, and negative predictive value (NPV) of 0.8845 in mice, and an AUROC of 0.7442, MCC of 0.4929, PPV of 0.6435, and NPV of 0.8539 in rats (Table <xref rid="Tab3" ref-type="table">3</xref>). Based on these results, we used RF models with SMOTE in both mice and rats in the PredAOT framework.<fig id="Fig2"><label>Fig. 2</label><caption><p>Cross-validation prediction performances of the MPNN, MPNN with MF, MPNN with MD, RF, SVM, and ANN models for the AOT classifier using mouse (<bold>A</bold>) and rat (<bold>B</bold>) datasets. Each performance metric value was calculated by five-fold cross-validation. MPNN, message passing neural network; MF, molecular fingerprint; MD, molecular descriptor; RF, random forest; SVM, support vector machine; ANN, artificial neural network</p></caption><graphic xlink:href="12859_2023_5176_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Cross-validation prediction performances of RF models with and without SMOTE using mouse (<bold>A</bold>) and rat (<bold>B</bold>) datasets. MPNN, message passing neural network; RF, random forest; SVM, support vector machine; ANN, artificial neural network</p></caption><graphic xlink:href="12859_2023_5176_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab3"><label>Table 3</label><caption><p>Prediction performance of classification models in PredAOT on the test dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">AUROC</th><th align="left">MCC</th><th align="left">PPV</th><th align="left">NPV</th></tr></thead><tbody><tr><td align="left">Mouse</td><td char="." align="char">0.7778</td><td char="." align="char">0.5514</td><td char="." align="char">0.6627</td><td char="." align="char">0.8845</td></tr><tr><td align="left">Rat</td><td char="." align="char">0.7442</td><td char="." align="char">0.4929</td><td char="." align="char">0.6435</td><td char="." align="char">0.8539</td></tr></tbody></table><table-wrap-foot><p>AUROC, area under receiver operating characteristic; MCC, Matthew’s correlation coefficient; PPV, positive predictive value; NPV, negative predictive value</p></table-wrap-foot></table-wrap></p>
      <p id="Par31">As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, the AOT of the compound was first predicted to be “toxic” or “less or non-toxic” using an AOT classifier in mice and rats. The LD<sub>50</sub> value (mg/kg) was subsequently quantitatively predicted using one of the regression models (i.e., “toxic regressor” or “less or non-toxic regressor”) according to the prediction result of the AOT classifier. Here, we optimized both regressors (i.e., “toxic regressor” or “less or non-toxic regressor”). The prediction performance of these regressors was evaluated through five-fold cross-validation using the training dataset. The root-mean-square error (RMSE) was used as the performance metric for the regression models. Consequently, RF showed the lowest RMSE, i.e., the best performance, in the "toxic regressor” and “less or non-toxic regressor” in both mice and rats. The RF model for both regressors showed an RMSE of 0.2999 and 0.3767 in mice, respectively (Figs. <xref rid="Fig4" ref-type="fig">4</xref>A, <xref rid="Fig5" ref-type="fig">5</xref>A) and 0.3919 and 0.4984 in rats, respectively (Figs. <xref rid="Fig4" ref-type="fig">4</xref>B, <xref rid="Fig5" ref-type="fig">5</xref>B). Thereafter, we evaluated the prediction performance using the test dataset. In mice, the toxic regressor showed an RMSE of 0.3806 and an R<sup>2</sup> of 0.3557 on the test dataset (Table <xref rid="Tab4" ref-type="table">4</xref>), whereas the less or non-toxic regressor showed an RMSE of 0.2923 and an R<sup>2</sup> of 0.3881. In rats, the toxic regressor showed an RMSE of 0.5323 and an R<sup>2</sup> of 0.3065 on the test dataset, whereas the less or non-toxic regressor showed an RMSE of 0.3863 and an R<sup>2</sup> of 0.2702.<fig id="Fig4"><label>Fig. 4</label><caption><p>Cross-validation prediction performances of the MPNN, MPNN with MF, MPNN with MD, RF, SVM, and ANN models for toxic regressors using mouse (<bold>A</bold>) and rat (<bold>B</bold>) toxic datasets (i.e., LD<sub>50</sub> ≤ 300 mg/kg). MPNN, message passing neural network; MF, molecular fingerprint; MD, molecular descriptor; RF, random forest; SVM, support vector machine; ANN, artificial neural network</p></caption><graphic xlink:href="12859_2023_5176_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Cross-validation prediction performances of the MPNN, MPNN with MF, MPNN with MD, RF, SVM and ANN models for the non-toxic regressor using mouse (<bold>A</bold>) and rat (<bold>B</bold>) less or non-toxic datasets (i.e., LD<sub>50</sub> &gt; 300 mg/kg). MPNN, message passing neural network; MF, molecular fingerprint; MD, molecular descriptor; RF, random forest; SVM, support vector machine; ANN, artificial neural network</p></caption><graphic xlink:href="12859_2023_5176_Fig5_HTML" id="MO5"/></fig><table-wrap id="Tab4"><label>Table 4</label><caption><p>Prediction performance of regression models in PredAOT on the test dataset<bold>.</bold> RMSE and R<sup>2</sup> values are calculated using log10 transformed LD50 values</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Regression model</th><th align="left">RMSE</th><th align="left">R<sup>2</sup></th></tr></thead><tbody><tr><td align="left" rowspan="2">Mouse</td><td align="left">Less or non-toxic</td><td char="." align="char">0.2923</td><td char="." align="char">0.3881</td></tr><tr><td align="left">Toxic</td><td char="." align="char">0.3806</td><td char="." align="char">0.3557</td></tr><tr><td align="left" rowspan="2">Rat</td><td align="left">Less or non-toxic</td><td char="." align="char">0.3863</td><td char="." align="char">0.2702</td></tr><tr><td align="left">Toxic</td><td char="." align="char">0.5323</td><td char="." align="char">0.3065</td></tr></tbody></table><table-wrap-foot><p>RMSE, root mean squared error; R<sup>2</sup>, R-squared</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec5">
      <title>Prediction performance of PredAOT compared with other prediction models</title>
      <p id="Par32">We compared the prediction performance of PredAOT with that of other existing tools. First, we compared the prediction performance of PredAOT in mice. Thereafter, we compared the prediction performance of PredAOT with OCHEM Predictor using our test dataset [<xref ref-type="bibr" rid="CR7">7</xref>]. The OCHEM Predictor predicted the LD<sub>50</sub> (mg/kg) result in the same manner as PredAOT, such that predicted values could be directly compared. We compared the prediction performance for each toxicity group in Table <xref rid="Tab1" ref-type="table">1</xref>. PredAOT yields relatively low RMSE values (i.e., improved performance) in groups with relatively little training data (e.g., Categories 1 and 2) (Table <xref rid="Tab5" ref-type="table">5</xref>). Notably, the performance comparison indicates that the test dataset may have been used as training data in OCHEM Predictor.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Comparison of RMSE values predicted by PredAOT with OCHEM Predictor on the mouse test dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Toxicity category</th><th align="left">OCHEM Predictor</th><th align="left">PredAOT</th></tr></thead><tbody><tr><td align="left">Category 1</td><td char="." align="char">193.11</td><td char="." align="char">82.13</td></tr><tr><td align="left">Category 2</td><td char="." align="char">273.24</td><td char="." align="char">294.64</td></tr><tr><td align="left">Category 3</td><td char="." align="char">805.42</td><td char="." align="char">289.55</td></tr><tr><td align="left">Category 4</td><td char="." align="char">513.90</td><td char="." align="char">533.00</td></tr><tr><td align="left">Category 5</td><td char="." align="char">1645.57</td><td char="." align="char">1645.25</td></tr></tbody></table><table-wrap-foot><p>RMSE, root mean squared error</p></table-wrap-foot></table-wrap></p>
      <p id="Par33">Second, we compared the prediction performance of PredAOT in rats with that of BESTox and aiQSAR using our test dataset [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. The prediction results of BESTox and aiQSAR were not directly comparable with the prediction results of PredAOT ​​because the unit for LD<sub>50</sub> was not mg/kg. Therefore, we compared the prediction results using two correlation coefficients: Pearson’s correlation coefficient (Pearson’s r) and Spearman's rank correlation coefficient (Spearman's r). PredAOT showed the highest Pearson’s r of 0.7984 and Spearman's r of 0.7340 compared to BESTox and aiQSAR (Table <xref rid="Tab6" ref-type="table">6</xref>).<table-wrap id="Tab6"><label>Table 6</label><caption><p>Comparative performance evaluation of PredAOT with BESTox and aiQSAR on the rat test dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Pearson's r</th><th align="left">Spearman's r</th></tr></thead><tbody><tr><td align="left">BESTox</td><td char="." align="char">0.7170</td><td char="." align="char">0.6978</td></tr><tr><td align="left">aiQSAR</td><td char="." align="char">− 0.8989</td><td char="." align="char">− 0.8918</td></tr><tr><td align="left">PredAOT</td><td char="." align="char">0.7984</td><td char="." align="char">0.7639</td></tr></tbody></table></table-wrap></p>
      <p id="Par34">Although we did not compare LD<sub>50</sub> values directly, PredAOT performed comparably or better than existing tools. PredAOT does not outperform other existing tools; however, it can be a useful tool for predicting AOT. In addition, it has the advantage of being able to predict AOT in mice and rats simultaneously.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Conclusions</title>
    <p id="Par35">In the present study, we developed a computational framework called PredAOT, which predicts the AOT of a given compound in mice and rats. PredAOT first classifies the given compound as “toxic” or “less or non-toxic”, and then further qualitatively predicts the LD<sub>50</sub> value using a regression model. PredAOT is trained with information on the AOT of 6,226 and 6,238 compounds in mice and rats, respectively. PredAOT has the advantage of predicting AOT in mice and rats simultaneously, and its prediction performance is similar to or better than that of existing tools. The web server for implementing PredAOT is available at <ext-link ext-link-type="uri" xlink:href="https://predaot.netlify.app/">https://predaot.netlify.app/</ext-link> (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). PredAOT will be a useful tool for the quick and accurate prediction of the AOT of small compounds in mice and rats for successful drug development.<fig id="Fig6"><label>Fig. 6</label><caption><p>User interface of the PredAOT web server</p></caption><graphic xlink:href="12859_2023_5176_Fig6_HTML" id="MO6"/></fig></p>
  </sec>
  <sec id="Sec7">
    <title>Methods</title>
    <sec id="Sec8">
      <title>Data preparation</title>
      <p id="Par36">Information on acute oral toxicity (AOT) of 6,226 compounds determined in mice was obtained from the OCHEM database [<xref ref-type="bibr" rid="CR7">7</xref>], and information on AOT of 6,238 compounds determined in rats was obtained from the literature [<xref ref-type="bibr" rid="CR6">6</xref>]. We defined compounds with lethal dose 50 (LD<sub>50</sub>) values ≤ 300 mg/kg as “toxic” and compounds with LD<sub>50</sub> values &gt; 300 mg/kg as “less or non-toxic”. The dataset was divided into training (80%) and test (20%) datasets. The training dataset was used for hyperparameter optimization, and the test dataset was used for model evaluation (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). During the model training and evaluation, we used log10 transformed LD50 values.</p>
    </sec>
    <sec id="Sec9">
      <title>Preparation of molecular features</title>
      <p id="Par37">The structures of the compounds were presented in the simplified molecular-input line-entry system (SMILES) format [<xref ref-type="bibr" rid="CR14">14</xref>]. To train message-passing neural networks (MPNNs), we used the Chemprop Python package [<xref ref-type="bibr" rid="CR15">15</xref>]. The RDKit Python package was used to calculate the molecular fingerprint. Extended connectivity fingerprints with a maximum diameter parameter of 4 (ECFP4) were used [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
    </sec>
    <sec id="Sec10">
      <title>Optimization of machine learning algorithms</title>
      <p id="Par38">In this study, we tested six different machine learning (ML) algorithms, including MPNN, MPNN with molecular fingerprints, MPNN with molecular descriptors, random forest (RF), support vector machine (SVM), and artificial neural network (ANN) models, to build both classification and regression models for predicting AOT in mice and rats. Here, the RF, SVM, and ANN models were trained using molecular fingerprints as input features. MPNN learns directly from a molecular graph to predict molecular properties [<xref ref-type="bibr" rid="CR15">15</xref>]. ANN is an ML algorithm inspired by the biological neuronal network of the human brain [<xref ref-type="bibr" rid="CR17">17</xref>]. The ANN structure consisted of an input layer, hidden layer(s), and an output layer. The ANN learns non-linear relationships from the data. RF is an ensemble learning algorithm that constructs multiple decision trees [<xref ref-type="bibr" rid="CR18">18</xref>]. The ANN algorithm was implemented using the Keras package (version 2.2.5) with TensorFlow backend (version 2.0.0) [<xref ref-type="bibr" rid="CR19">19</xref>]. The RF and SVM algorithms were implemented using the <italic>scikit-learn</italic> Python package [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p id="Par39">To build the optimal model with the best prediction performance, hyperparameter optimization was performed. For the classification model, we selected the optimal hyperparameter that showed the highest accuracy (ACC) using the grid-search cross-validation method. In addition, for the regression model, we selected the optimal hyperparameter that showed the lowest root mean square error (RMSE) using the grid search cross-validation method.</p>
      <p id="Par40">Five metrics were used to evaluate the performance of the classification model: ACC, area under the receiver operating characteristic (AUROC), Matthew’s correlation coefficient (MCC), positive predictive value (PPV), and negative predictive value (NPV). In addition, to evaluate the regression model performance, two performance metrics were used: the RMSE and R-squared value (R<sup>2</sup>).</p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>ACC</term>
        <def>
          <p id="Par5">Highest accuracy</p>
        </def>
      </def-item>
      <def-item>
        <term>ANN</term>
        <def>
          <p id="Par6">Artificial neural network</p>
        </def>
      </def-item>
      <def-item>
        <term>AOT</term>
        <def>
          <p id="Par7">Acute oral toxicity</p>
        </def>
      </def-item>
      <def-item>
        <term>AUROC</term>
        <def>
          <p id="Par8">Area under the receiver operating characteristic</p>
        </def>
      </def-item>
      <def-item>
        <term>LD<sub>50</sub></term>
        <def>
          <p id="Par9">Lethal dose 50</p>
        </def>
      </def-item>
      <def-item>
        <term>ML</term>
        <def>
          <p id="Par10">Machine learning</p>
        </def>
      </def-item>
      <def-item>
        <term>MCC</term>
        <def>
          <p id="Par11">Matthew’s correlation coefficient</p>
        </def>
      </def-item>
      <def-item>
        <term>MPNN</term>
        <def>
          <p id="Par12">Message passing neural network</p>
        </def>
      </def-item>
      <def-item>
        <term>NPV</term>
        <def>
          <p id="Par13">Negative predictive value</p>
        </def>
      </def-item>
      <def-item>
        <term>PPV</term>
        <def>
          <p id="Par14">Positive predictive value</p>
        </def>
      </def-item>
      <def-item>
        <term>RF</term>
        <def>
          <p id="Par15">Random forest</p>
        </def>
      </def-item>
      <def-item>
        <term>RMSE</term>
        <def>
          <p id="Par16">Root-mean-square error</p>
        </def>
      </def-item>
      <def-item>
        <term>SMOTE</term>
        <def>
          <p id="Par17">Synthetic minority oversampling technique</p>
        </def>
      </def-item>
      <def-item>
        <term>SMILES</term>
        <def>
          <p id="Par18">Simplified molecular-input line-entry system</p>
        </def>
      </def-item>
      <def-item>
        <term>SVM</term>
        <def>
          <p id="Par19">Support vector machine</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable<bold>.</bold></p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>J.Y.R. and K.S.O. designed the research; J.Y.R. developed the prediction model; J.Y.R., J.D.J., and W.D.J. analyzed the data; All authors have read and approved the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government(MSIT) (nos. NRF-2020R1C1C1003218 and 2022M3J4A1091452). This work was also funded by the Korea Research Institute of Chemical Technology (no. SI2231-30-0221082086810001).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The data and source code are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/CSB-L/PredAOT">https://github.com/CSB-L/PredAOT</ext-link>, and the PredAOT web server is available at <ext-link ext-link-type="uri" xlink:href="https://predaot.netlify.app">https://predaot.netlify.app</ext-link>. The datasets supporting the conclusions of this study are available from the corresponding author upon reasonable request.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par41">Not applicable.</p>
    </notes>
    <notes id="FPar2">
      <title>Consent for publication</title>
      <p id="Par42">Not applicable.</p>
    </notes>
    <notes id="FPar3" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par43">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kramer</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Sagartz</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>DL</given-names>
          </name>
        </person-group>
        <article-title>The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates</article-title>
        <source>Nat Rev Drug Discov</source>
        <year>2007</year>
        <volume>6</volume>
        <issue>8</issue>
        <fpage>636</fpage>
        <lpage>649</lpage>
        <pub-id pub-id-type="doi">10.1038/nrd2378</pub-id>
        <?supplied-pmid 17643090?>
        <pub-id pub-id-type="pmid">17643090</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Holt</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Nuttall</surname>
            <given-names>JP</given-names>
          </name>
        </person-group>
        <article-title>Preclinical safety evaluation</article-title>
        <source>Curr Top Microbiol Immunol</source>
        <year>2014</year>
        <volume>383</volume>
        <fpage>55</fpage>
        <lpage>78</lpage>
        <?supplied-pmid 23612993?>
        <pub-id pub-id-type="pmid">23612993</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <mixed-citation publication-type="other">OCED: Test No. 425: acute oral toxicity: up-and-down procedure, OECD guidelines for the testing of chemicals, section 4. In<italic>: 2008; Paris</italic>. OECD Publishing.</mixed-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Balls</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Why modification of the LD50 test will not be enough</article-title>
        <source>Lab Anim</source>
        <year>1991</year>
        <volume>25</volume>
        <issue>3</issue>
        <fpage>198</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.1258/002367791780808310</pub-id>
        <?supplied-pmid 1921314?>
        <pub-id pub-id-type="pmid">1921314</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Walum</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Acute oral toxicity</article-title>
        <source>Environ Health Perspect</source>
        <year>1998</year>
        <volume>106</volume>
        <issue>Suppl 2</issue>
        <fpage>497</fpage>
        <lpage>503</lpage>
        <pub-id pub-id-type="doi">10.1289/ehp.98106497</pub-id>
        <?supplied-pmid 9599698?>
        <pub-id pub-id-type="pmid">9599698</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gadaleta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vukovic</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Toma</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lavado</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Karmaus</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Mansouri</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kleinstreuer</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Benfenati</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Roncaglioni</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>SAR and QSAR modeling of a large collection of LD50 rat acute oral toxicity data</article-title>
        <source>J Cheminform</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>58</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-019-0383-2</pub-id>
        <?supplied-pmid 33430989?>
        <pub-id pub-id-type="pmid">33430989</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sushko</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Novotarskyi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Korner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pandey</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Rupp</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Teetz</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Brandmaier</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Abdelaziz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Prokopenko</surname>
            <given-names>VV</given-names>
          </name>
          <name>
            <surname>Tanchuk</surname>
            <given-names>VY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Online chemical modeling environment (OCHEM): web platform for data storage, model development and publishing of chemical information</article-title>
        <source>J Comput Aided Mol Des</source>
        <year>2011</year>
        <volume>25</volume>
        <issue>6</issue>
        <fpage>533</fpage>
        <lpage>554</lpage>
        <pub-id pub-id-type="doi">10.1007/s10822-011-9440-2</pub-id>
        <?supplied-pmid 21660515?>
        <pub-id pub-id-type="pmid">21660515</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garcia-Jacas</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Marrero-Ponce</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cortes-Guzman</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Suarez-Lezcano</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Martinez-Rios</surname>
            <given-names>FO</given-names>
          </name>
          <name>
            <surname>Garcia-Gonzalez</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Pupo-Merino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Martinez-Mayorga</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Enhancing acute oral toxicity predictions by using consensus modeling and algebraic form-based 0D-to-2D molecular encodes</article-title>
        <source>Chem Res Toxicol</source>
        <year>2019</year>
        <volume>32</volume>
        <issue>6</issue>
        <fpage>1178</fpage>
        <lpage>1192</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.chemrestox.9b00011</pub-id>
        <?supplied-pmid 31066547?>
        <pub-id pub-id-type="pmid">31066547</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vukovic</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gadaleta</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Benfenati</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Methodology of aiQSAR: a group-specific approach to QSAR modelling</article-title>
        <source>J Cheminform</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-019-0350-y</pub-id>
        <?supplied-pmid 30945010?>
        <pub-id pub-id-type="pmid">30945010</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <mixed-citation publication-type="other">Chen J, Cheong H-H, Siu SWI. BESTox: a convolutional neural network regression model based on binary-encoded SMILES for acute oral toxicity prediction of chemical compounds. Proc Int Conf Algorithms Comput Biol 2020:155–166.</mixed-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Green</surname>
            <given-names>JA</given-names>
          </name>
        </person-group>
        <article-title>Too many zeros and/or highly skewed? A tutorial on modelling health behaviour as count data with Poisson and negative binomial regression</article-title>
        <source>Health Psychol Behav Med</source>
        <year>2021</year>
        <volume>9</volume>
        <issue>1</issue>
        <fpage>436</fpage>
        <lpage>455</lpage>
        <pub-id pub-id-type="doi">10.1080/21642850.2021.1920416</pub-id>
        <?supplied-pmid 34104569?>
        <pub-id pub-id-type="pmid">34104569</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <mixed-citation publication-type="other">Administration UNAaR: Code of federal regulations, protection of environment, title 40, sec. 156.62. In: 2006.</mixed-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blagus</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lusa</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>SMOTE for high-dimensional class-imbalanced data</article-title>
        <source>BMC Bioinform</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>106</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-14-106</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <mixed-citation publication-type="other">Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 1988, 28:31–36.</mixed-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Swanson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Coley</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Eiden</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Guzman-Perez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hopper</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mathea</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Analyzing learned molecular representations for property prediction</article-title>
        <source>J Chem Inf Model</source>
        <year>2019</year>
        <volume>59</volume>
        <issue>8</issue>
        <fpage>3370</fpage>
        <lpage>3388</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00237</pub-id>
        <?supplied-pmid 31361484?>
        <pub-id pub-id-type="pmid">31361484</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rogers</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hahn</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Extended-connectivity fingerprints</article-title>
        <source>J Chem Inf Model</source>
        <year>2010</year>
        <volume>50</volume>
        <issue>5</issue>
        <fpage>742</fpage>
        <lpage>754</lpage>
        <pub-id pub-id-type="doi">10.1021/ci100050t</pub-id>
        <?supplied-pmid 20426451?>
        <pub-id pub-id-type="pmid">20426451</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Angermueller</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Parnamaa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Parts</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Stegle</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>Deep learning for computational biology</article-title>
        <source>Mol Syst Biol</source>
        <year>2016</year>
        <volume>12</volume>
        <issue>7</issue>
        <fpage>878</fpage>
        <pub-id pub-id-type="doi">10.15252/msb.20156651</pub-id>
        <?supplied-pmid 27474269?>
        <pub-id pub-id-type="pmid">27474269</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <mixed-citation publication-type="other">Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Goldring MB, Borea PA, Varani K. Pulsed electromagnetic fields increased the anti-inflammatory effect of A(2)A and A(3) adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. PLoS ONE 2013, 8(5):e65561.</mixed-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <mixed-citation publication-type="other">Abadi M, Barham P, Chen JM, Chen ZF, Davis A, Dean J, Devin M, Ghemawat S, Irving G, Isard M, et al. TensorFlow: a system for large-scale machine learning. Proceedings of Osdi'16: 12th Usenix Symposium on Operating Systems Design and Implementation 2016:265–283.</mixed-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedregosa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Varoquaux</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gramfort</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Michel</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Thirion</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Grisel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Blondel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Prettenhofer</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dubourg</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Scikit-learn: machine learning in python</article-title>
        <source>J Mach Learn Res</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>2825</fpage>
        <lpage>2830</lpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
